Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells
about
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyLeukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptorThe orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptorExpression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1RMultiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery.Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosaCysteinyl leukotrienes: multi-functional mediators in allergic rhinitisDetermination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitisThe leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implicationsCysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System DisordersA review on leukotrienes and their receptors with reference to asthmaCharacterization of interleukin-4-stimulated nasal polyp fibroblasts.Leukotriene Inhibitors in Sinusitis.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsDifferential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach.Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.Modulation of mast cell proliferative and inflammatory responses by leukotriene d4 and stem cell factor signaling interactions.CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cellsPharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell functionUDP acting at P2Y6 receptors is a mediator of microglial phagocytosisCysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonistsIntracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretionLeukotriene receptors in atherosclerosis.Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation.The mast cell and allergic diseases: role in pathogenesis and implications for therapy.P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells.Structural and functional evolution of the P2Y(12)-like receptor group.CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.Enhancement by Uridine Diphosphate of Macrophage Inflammatory Protein-1 Alpha Production in Microglia Derived from Sandhoff Disease Model Mice.Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Cysteinyl leukotriene receptors, old and new; implications for asthma.The role of leukotrienes in immunopathogenesis of rheumatoid arthritis.Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17.
P2860
Q24629255-761BDDDA-C0CC-4308-BB67-C7005AF9A9CFQ24647514-57C7C21A-BCC5-47C4-881B-C1C6C2E98C7BQ24672638-676F2E9C-E700-4371-AFF5-4B7C0E167940Q24673057-5912C8C3-CDAC-4398-8F3F-78B79B6653ADQ24816682-1F13E4DC-0271-45E1-B790-B2EF8CED5003Q28209228-7359D2E0-F6F5-4AE7-96F5-11A73CBDDCCFQ28219122-9AEF755F-684C-4990-BD95-DC9776AFA066Q28245735-46A4DAC6-1126-4CCB-9D86-3AB30B8FC5E0Q28253643-7F644EAD-7E10-42C3-AB7A-EDAB0C3ED14AQ28278005-F756E8B9-CBB6-427B-8572-ECC234AFF992Q28294597-59D01D66-0EF6-459C-A51C-175C81C8DC80Q30311131-333CA0E2-D919-42DC-A33A-3BC95E214D84Q30455019-D5CBDD2E-C125-468A-8F62-C47DF4BBA654Q30486707-C1961F78-7CC8-4BDC-844B-F92EB6F66CAFQ31027582-505D613B-58E7-4FD2-BA88-E244A198B9C7Q33340702-F02187F2-9356-46D7-A7D0-FCE778253248Q33541287-BDF4204D-A153-4313-89EA-A4C1133B0D35Q33677296-24EFB248-EDF9-4FBA-97C7-1A7B885EF661Q34572441-E1FD3A5C-839A-4BD3-9D44-31E801E13116Q34662206-241DCC7D-2A7D-4864-A920-A0435F04148BQ34971386-EE333C64-D464-455D-8FAE-92DB31B5881EQ35044822-1FCFBD22-23A8-418B-A08E-51F017299FF3Q36240870-AFBA2ECF-FB77-4AB2-8E70-D98C950D4061Q36298197-4F04E067-B974-46C1-8C2E-CE591DDB0A03Q36370341-DF9B731D-F9EA-4707-BE81-1EE90D83D608Q36371243-B0B7F6F0-9F6E-420A-9B1C-0E266CCA485EQ36652544-30716B9B-96EE-48BC-9370-3F2BE873A0E7Q36711106-F714298D-4644-454B-A482-53669B5F7C94Q36819905-D683CB3B-26C6-4FC6-83E5-D52465549EE8Q37010493-C3302649-B2FC-4B8C-AEAD-E4BB2040148AQ37041271-E55CD096-9B86-4CF8-8BF5-F62CF1E97DB5Q37135510-CC5FEECE-8C72-4AE1-8883-B8B8BB568C98Q37140406-06F87558-3B73-4053-81B2-9B13BE9E3958Q37329253-23750321-A6B8-41E4-AF2F-6429C2511B93Q37713745-BE6C1C49-F51D-49A8-9CA9-91FA968803F0Q37995534-FAFDECCA-8092-494F-887E-BB61383CEE88Q38038319-00800970-A101-4EAC-B242-4BF9A4017374Q38193193-70480494-9F7F-4138-BA3F-A5AC74AE30A3Q38728679-FEE1B0CF-050C-4741-ADC1-99F8CEA3870DQ39393180-5D30F816-BDEB-4C55-B108-BB9298016FE2
P2860
Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@ast
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@en
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@nl
type
label
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@ast
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@en
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@nl
prefLabel
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@ast
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@en
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@nl
P2093
P2860
P356
P1476
Cysteinyl leukotriene receptor ...... expressed by human mast cells
@en
P2093
P2860
P304
P356
10.1073/PNAS.141221498
P407
P577
2001-07-03T00:00:00Z